+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Pharmacokinetics of haloperidol and reduced haloperidol in Chinese schizophrenic patients after intravenous and oral administration of haloperidol



Pharmacokinetics of haloperidol and reduced haloperidol in Chinese schizophrenic patients after intravenous and oral administration of haloperidol



Psychopharmacology 106(4): 517-522



The pharmacokinetics of haloperidol were studied in eight Chinese schizophrenic patients after intravenous administration and in six of the patients who also received oral haloperidol. After intravenous dosing, haloperidol disposition was best characterized by a three compartment model. The mean elimination half-life of 54.8 h determined by model dependent analysis was similar to the mean elimination half-life of 59.9 h determined by model independent analysis. The mean plasma clearance was 21.71/h and the mean volume of distribution during the distribution phase was 1754.3 1. After oral dosing, bioavailability of haloperidol was 35 +/- 8%, suggesting extensive first pass metabolism. Determination of reduced haloperidol concentration confirmed a previous finding of significant variability in haloperidol reductive capacity in individual patients. Comparison of area under the plasma concentration-time curve of reduced haloperidol after intravenous and oral administration of haloperidol suggests that reduction of haloperidol may only account for a small portion of first pass metabolism of haloperidol. However, conversion of reduced haloperidol back to haloperidol necessitates the monitoring of both haloperidol and reduced haloperidol concentrations in clinical practice.

(PDF emailed within 0-6 h: $19.90)

Accession: 040958465

Download citation: RISBibTeXText

PMID: 1579624

DOI: 10.1007/bf02244824


Related references

The plasma haloperidol and reduced haloperidol concentrations in chinese schizophrenic patients relationship between reduced haloperidol haloperidol ratio and red blood cell haloperidol reductase activity. Human Psychopharmacology 7(2): 123-128, 1992

The plasma haloperidol and reduced haloperidol concentrations in chinese schizophrenic patients: Relationship between reduced haloperidol/haloperidol ratio and red blood cell haloperidol reductase activity. Human Psychopharmacology: Clinical and Experimental 7(2): 123-128, 1992

Haloperidol hl and reduced haloperidol rh kinetics after intravenous and oral doses in chinese schizophrenic patients. Pharmaceutical Research (New York) 8(10 SUPPL): S302, 1991

Steady state plasma concentrations of haloperidol and reduced haloperidol after oral haloperidol in schizophrenic patients and analysis of factors determining their concentrations in hair. Japanese Journal of Pharmacology 55(SUPPL 1): 102P, 1991

Simultaneous determination of plasma haloperidol and its metabolite reduced haloperidol by liquid chromatography with electrochemical detection: Plasma levels in schizophrenic patients treated with oral or intramuscular depot haloperidol. Journal of Chromatography B Biomedical Applications 656(2): 373-381, 1994

Ketone reductase activity and reduced haloperidol/haloperidol ratios in haloperidol-treated schizophrenic patients. Psychiatry Research. 57(2): 101-108, 1995

Plasma reduced haloperidol/haloperidol ratios in schizophrenic patients treated with high dosages of haloperidol. European Neuropsychopharmacology 4(2): 119-126, 1994

Pharmacodynamics and pharmacokinetics of haloperidol and reduced haloperidol in schizophrenic patients. Biological Psychiatry 26(3): 239-249, 1989

Reduced haloperidol/haloperidol ratios after oral haloperidol and decanoate administration in schizophrenics. Progress in Neuro-Psychopharmacology & Biological Psychiatry 17(1): 105-112, 1993

Reversible metabolism of haloperidol and reduced haloperidol in chinese schizophrenic patients. Pharmacotherapy 9(3): 196, 1989

Reversible metabolism of haloperidol and reduced haloperidol in Chinese schizophrenic patients. Psychopharmacology 101(1): 107-111, 1990

Steady-state pharmacokinetics of haloperidol and reduced haloperidol in schizophrenic patients: Analysis of factors determining their concentrations in hair. Journal of Pharmaceutical Sciences 81(10): 1008-1011, 1992

Formation of Reduced Haloperidol after Intramuscular Haloperidol Administration in Schizophrenic Patients. Drug Investigation. 7(1): 18-25, 1994

Disposition of Haloperidol and Reduced Haloperidol Plasma Levels After Single Dose Haloperidol Decanoate Administration. Human Psychopharmacology. 10(1): 47-51, 1995

Haloperidol and reduced haloperidol concentrations in plasma from chronic schizophrenic patients. European Journal of Pharmacology 183(6): 2301-2302, 1990